Clinical Trial Update: Blinatumomab for CNI-Resistant/Intolerant SRNS in Children [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating blinatumomab for children with calcineurin inhibitor–resistant or intolerant steroid-resistant nephrotic syndrome; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome
• Steroid-resistant Nephrotic Syndrome

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: CNI-resistant Steriod Resistant Nephrotic Syndrome, CNI-intolerent | Phase 1 | Status: RECRUITING